(Q24244719)

title

Risperidone alone or in combination for acute mania (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984671&resulttype=core&format=json

14 May 2020

1 reference

4

G M Goodwin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984671&resulttype=core&format=json

14 May 2020

author name string

J M Rendell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984671&resulttype=core&format=json

14 May 2020

H J Gijsman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984671&resulttype=core&format=json

14 May 2020

M S Bauer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984671&resulttype=core&format=json

14 May 2020

G R Geddes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984671&resulttype=core&format=json

Cochrane Database of Systematic Reviews

14 May 2020

publication date

25 January 2006

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984671&resulttype=core&format=json

14 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984671&resulttype=core&format=json

14 May 2020

page(s)

CD004043

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984671&resulttype=core&format=json

Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004043.PUB2

Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004043.PUB2

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004043.PUB2

Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004043.PUB2

The association between funding by commercial interests and study outcome in randomized controlled drug trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004043.PUB2

Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16437472

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Olanzapine alone or in combination for acute mania

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16437472

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The case of the missing data: methods of dealing with dropouts and other research vagaries

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16437472

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/14651858.CD004043.PUB2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984671&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6984671&resulttype=core&format=json

14 May 2020

PubMed publication ID

16437472

1 reference